[Federal Register Volume 61, Number 54 (Tuesday, March 19, 1996)]
[Notices]
[Page 11216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-6586]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Cancer Institute; Notice of Closed Meeting
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the National Cancer Institute Special Emphasis Panel (SEP):
Name of SEP: Cancer Prevention Research Unit.
Date: March 26-28, 1996.
Time: March 26--7 p.m. to 12:00 p.m.; March 27--8 a.m. to 5:00
p.m.; March 28--8 a.m. to adjournment.
Place: The Double Tree Hotel, 1750 Rockville Pike, Bethesda, MD
20852.
Contact Person: Dr. Gerald Lovinger, Scientific Review
Administrator, National Cancer Institute, NIH, Executive Plaza
North, Room 630C, 6130 Executive Boulevard MSC 7405, Bethesda, MD
20892-7405, Telephone: 301/496-7987.
Purpose/Agenda: This meeting will be devoted to the review,
discussion, and evaluation of grant applications.
The meeting will be closed in accordance with the provisions set
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
This notice is being published less than 15 days prior to the
meeting due to the urgent need to meet timing limitations imposed by
the review and funding cycle.
(Catalog of Federal Domestic Assistance Program Numbers: 93.393,
Cancer Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control.)
Dated: March 13, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-6586 Filed 3-18-96; 8:45 am]
BILLING CODE 4140-01-M
